Global Ibandronate Market Size, Status and Forecast 2024-2031

Report ID: 917479 | Published Date: Sep 2024 | No. of Page: 99 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ibandronate Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Oral
        1.2.3 Injection
    1.3 Market by Application
        1.3.1 Global Ibandronate Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Drug store
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Ibandronate Market Perspective (2016-2027)
    2.2 Ibandronate Growth Trends by Regions
        2.2.1 Ibandronate Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Ibandronate Historic Market Share by Regions (2016-2021)
        2.2.3 Ibandronate Forecasted Market Size by Regions (2022-2027)
    2.3 Ibandronate Industry Dynamic
        2.3.1 Ibandronate Market Trends
        2.3.2 Ibandronate Market Drivers
        2.3.3 Ibandronate Market Challenges
        2.3.4 Ibandronate Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Ibandronate Players by Revenue
        3.1.1 Global Top Ibandronate Players by Revenue (2016-2021)
        3.1.2 Global Ibandronate Revenue Market Share by Players (2016-2021)
    3.2 Global Ibandronate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Ibandronate Revenue
    3.4 Global Ibandronate Market Concentration Ratio
        3.4.1 Global Ibandronate Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ibandronate Revenue in 2020
    3.5 Ibandronate Key Players Head office and Area Served
    3.6 Key Players Ibandronate Product Solution and Service
    3.7 Date of Enter into Ibandronate Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Ibandronate Breakdown Data by Type
    4.1 Global Ibandronate Historic Market Size by Type (2016-2021)
    4.2 Global Ibandronate Forecasted Market Size by Type (2022-2027)

5 Ibandronate Breakdown Data by Application
    5.1 Global Ibandronate Historic Market Size by Application (2016-2021)
    5.2 Global Ibandronate Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Ibandronate Market Size (2016-2027)
    6.2 North America Ibandronate Market Size by Type
        6.2.1 North America Ibandronate Market Size by Type (2016-2021)
        6.2.2 North America Ibandronate Market Size by Type (2022-2027)
        6.2.3 North America Ibandronate Market Size by Type (2016-2027)
    6.3 North America Ibandronate Market Size by Application
        6.3.1 North America Ibandronate Market Size by Application (2016-2021)
        6.3.2 North America Ibandronate Market Size by Application (2022-2027)
        6.3.3 North America Ibandronate Market Size by Application (2016-2027)
    6.4 North America Ibandronate Market Size by Country
        6.4.1 North America Ibandronate Market Size by Country (2016-2021)
        6.4.2 North America Ibandronate Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Ibandronate Market Size (2016-2027)
    7.2 Europe Ibandronate Market Size by Type
        7.2.1 Europe Ibandronate Market Size by Type (2016-2021)
        7.2.2 Europe Ibandronate Market Size by Type (2022-2027)
        7.2.3 Europe Ibandronate Market Size by Type (2016-2027)
    7.3 Europe Ibandronate Market Size by Application
        7.3.1 Europe Ibandronate Market Size by Application (2016-2021)
        7.3.2 Europe Ibandronate Market Size by Application (2022-2027)
        7.3.3 Europe Ibandronate Market Size by Application (2016-2027)
    7.4 Europe Ibandronate Market Size by Country
        7.4.1 Europe Ibandronate Market Size by Country (2016-2021)
        7.4.2 Europe Ibandronate Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Ibandronate Market Size (2016-2027)
    8.2 Asia-Pacific Ibandronate Market Size by Type
        8.2.1 Asia-Pacific Ibandronate Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Ibandronate Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Ibandronate Market Size by Type (2016-2027)
    8.3 Asia-Pacific Ibandronate Market Size by Application
        8.3.1 Asia-Pacific Ibandronate Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Ibandronate Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Ibandronate Market Size by Application (2016-2027)
    8.4 Asia-Pacific Ibandronate Market Size by Region
        8.4.1 Asia-Pacific Ibandronate Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Ibandronate Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Ibandronate Market Size (2016-2027)
    9.2 Latin America Ibandronate Market Size by Type
        9.2.1 Latin America Ibandronate Market Size by Type (2016-2021)
        9.2.2 Latin America Ibandronate Market Size by Type (2022-2027)
        9.2.3 Latin America Ibandronate Market Size by Type (2016-2027)
    9.3 Latin America Ibandronate Market Size by Application
        9.3.1 Latin America Ibandronate Market Size by Application (2016-2021)
        9.3.2 Latin America Ibandronate Market Size by Application (2022-2027)
        9.3.3 Latin America Ibandronate Market Size by Application (2016-2027)
    9.4 Latin America Ibandronate Market Size by Country
        9.4.1 Latin America Ibandronate Market Size by Country (2016-2021)
        9.4.2 Latin America Ibandronate Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Ibandronate Market Size (2016-2027)
    10.2 Middle East & Africa Ibandronate Market Size by Type
        10.2.1 Middle East & Africa Ibandronate Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Ibandronate Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Ibandronate Market Size by Type (2016-2027)
    10.3 Middle East & Africa Ibandronate Market Size by Application
        10.3.1 Middle East & Africa Ibandronate Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Ibandronate Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Ibandronate Market Size by Application (2016-2027)
    10.4 Middle East & Africa Ibandronate Market Size by Country
        10.4.1 Middle East & Africa Ibandronate Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Ibandronate Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Ibandronate Introduction
        11.1.4 Roche Revenue in Ibandronate Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Apotex
        11.2.1 Apotex Company Details
        11.2.2 Apotex Business Overview
        11.2.3 Apotex Ibandronate Introduction
        11.2.4 Apotex Revenue in Ibandronate Business (2016-2021)
        11.2.5 Apotex Recent Development
    11.3 Mylan
        11.3.1 Mylan Company Details
        11.3.2 Mylan Business Overview
        11.3.3 Mylan Ibandronate Introduction
        11.3.4 Mylan Revenue in Ibandronate Business (2016-2021)
        11.3.5 Mylan Recent Development
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Company Details
        11.4.2 Sun Pharmaceutical Business Overview
        11.4.3 Sun Pharmaceutical Ibandronate Introduction
        11.4.4 Sun Pharmaceutical Revenue in Ibandronate Business (2016-2021)
        11.4.5 Sun Pharmaceutical Recent Development
    11.5 Dr Reddy's Laboratories
        11.5.1 Dr Reddy's Laboratories Company Details
        11.5.2 Dr Reddy's Laboratories Business Overview
        11.5.3 Dr Reddy's Laboratories Ibandronate Introduction
        11.5.4 Dr Reddy's Laboratories Revenue in Ibandronate Business (2016-2021)
        11.5.5 Dr Reddy's Laboratories Recent Development
    11.6 Aurobindo Pharma
        11.6.1 Aurobindo Pharma Company Details
        11.6.2 Aurobindo Pharma Business Overview
        11.6.3 Aurobindo Pharma Ibandronate Introduction
        11.6.4 Aurobindo Pharma Revenue in Ibandronate Business (2016-2021)
        11.6.5 Aurobindo Pharma Recent Development
    11.7 MACLEODS
        11.7.1 MACLEODS Company Details
        11.7.2 MACLEODS Business Overview
        11.7.3 MACLEODS Ibandronate Introduction
        11.7.4 MACLEODS Revenue in Ibandronate Business (2016-2021)
        11.7.5 MACLEODS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Ibandronate Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oral
    Table 3. Key Players of Injection
    Table 4. Global Ibandronate Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Ibandronate Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Ibandronate Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Ibandronate Market Share by Regions (2016-2021)
    Table 8. Global Ibandronate Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Ibandronate Market Share by Regions (2022-2027)
    Table 10. Ibandronate Market Trends
    Table 11. Ibandronate Market Drivers
    Table 12. Ibandronate Market Challenges
    Table 13. Ibandronate Market Restraints
    Table 14. Global Ibandronate Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Ibandronate Market Share by Players (2016-2021)
    Table 16. Global Top Ibandronate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ibandronate as of 2020)
    Table 17. Ranking of Global Top Ibandronate Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Ibandronate Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Ibandronate Product Solution and Service
    Table 21. Date of Enter into Ibandronate Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Ibandronate Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Ibandronate Revenue Market Share by Type (2016-2021)
    Table 25. Global Ibandronate Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Ibandronate Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Ibandronate Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Ibandronate Revenue Market Share by Application (2016-2021)
    Table 29. Global Ibandronate Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Ibandronate Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Ibandronate Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Ibandronate Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Ibandronate Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Ibandronate Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Ibandronate Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Ibandronate Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Ibandronate Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Ibandronate Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Ibandronate Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Ibandronate Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Ibandronate Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Ibandronate Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Ibandronate Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Ibandronate Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Ibandronate Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Ibandronate Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Ibandronate Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Ibandronate Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Ibandronate Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Ibandronate Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Ibandronate Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Ibandronate Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Ibandronate Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Ibandronate Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Ibandronate Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Ibandronate Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Ibandronate Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Ibandronate Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Ibandronate Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Ibandronate Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Roche Company Details
    Table 62. Roche Business Overview
    Table 63. Roche Ibandronate Product
    Table 64. Roche Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 65. Roche Recent Development
    Table 66. Apotex Company Details
    Table 67. Apotex Business Overview
    Table 68. Apotex Ibandronate Product
    Table 69. Apotex Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 70. Apotex Recent Development
    Table 71. Mylan Company Details
    Table 72. Mylan Business Overview
    Table 73. Mylan Ibandronate Product
    Table 74. Mylan Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 75. Mylan Recent Development
    Table 76. Sun Pharmaceutical Company Details
    Table 77. Sun Pharmaceutical Business Overview
    Table 78. Sun Pharmaceutical Ibandronate Product
    Table 79. Sun Pharmaceutical Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 80. Sun Pharmaceutical Recent Development
    Table 81. Dr Reddy's Laboratories Company Details
    Table 82. Dr Reddy's Laboratories Business Overview
    Table 83. Dr Reddy's Laboratories Ibandronate Product
    Table 84. Dr Reddy's Laboratories Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 85. Dr Reddy's Laboratories Recent Development
    Table 86. Aurobindo Pharma Company Details
    Table 87. Aurobindo Pharma Business Overview
    Table 88. Aurobindo Pharma Ibandronate Product
    Table 89. Aurobindo Pharma Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 90. Aurobindo Pharma Recent Development
    Table 91. MACLEODS Company Details
    Table 92. MACLEODS Business Overview
    Table 93. MACLEODS Ibandronate Product
    Table 94. MACLEODS Revenue in Ibandronate Business (2016-2021) & (US$ Million)
    Table 95. MACLEODS Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ibandronate Market Share by Type: 2020 VS 2027
    Figure 2. Oral Features
    Figure 3. Injection Features
    Figure 4. Global Ibandronate Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Case Studies
    Figure 6. Drug store Case Studies
    Figure 7. Ibandronate Report Years Considered
    Figure 8. Global Ibandronate Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Ibandronate Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Ibandronate Market Share by Regions: 2020 VS 2027
    Figure 11. Global Ibandronate Market Share by Regions (2022-2027)
    Figure 12. Global Ibandronate Market Share by Players in 2020
    Figure 13. Global Top Ibandronate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ibandronate as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Ibandronate Revenue in 2020
    Figure 15. Global Ibandronate Revenue Market Share by Type (2016-2021)
    Figure 16. Global Ibandronate Revenue Market Share by Type (2022-2027)
    Figure 17. North America Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Ibandronate Market Share by Type (2016-2027)
    Figure 19. North America Ibandronate Market Share by Application (2016-2027)
    Figure 20. North America Ibandronate Market Share by Country (2016-2027)
    Figure 21. United States Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Ibandronate Market Share by Type (2016-2027)
    Figure 25. Europe Ibandronate Market Share by Application (2016-2027)
    Figure 26. Europe Ibandronate Market Share by Country (2016-2027)
    Figure 27. Germany Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Ibandronate Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Ibandronate Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Ibandronate Market Share by Region (2016-2027)
    Figure 37. China Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Ibandronate Market Share by Type (2016-2027)
    Figure 45. Latin America Ibandronate Market Share by Application (2016-2027)
    Figure 46. Latin America Ibandronate Market Share by Country (2016-2027)
    Figure 47. Mexico Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Ibandronate Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Ibandronate Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Ibandronate Market Share by Country (2016-2027)
    Figure 53. Turkey Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Ibandronate Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Roche Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 57. Apotex Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 58. Mylan Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 59. Sun Pharmaceutical Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 60. Dr Reddy's Laboratories Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 61. Aurobindo Pharma Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 62. MACLEODS Revenue Growth Rate in Ibandronate Business (2016-2021)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Apotex
Mylan
Sun Pharmaceutical
Dr Reddy's Laboratories
Aurobindo Pharma
MACLEODS
Frequently Asked Questions
Ibandronate report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ibandronate report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ibandronate report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Symlin (pramlintide)

SYMLIN® (pramlintide acetate) injection is an anti-diabetic medication for use in patients with  ... Read More

Ramelteon

Ramelteon, marketed as Rozerem among others, is a sleep agent that selectively binds to the MT1 a ... Read More

Ranolazine

Ranolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that w ... Read More

Tipranavir

Tipranavir (TPV), or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured b ... Read More